Dengue viruses (DENV) are emerging, mosquito-borne Flaviviruses and the agents of dengue fever (DF) and dengue hemorrhagic fever (DHF). The NIAID has listed dengue (DEN) as a category A priority agent with respect to Biodefense and Emerging Infections research. A large body of work has demonstrated that people infected with DENV develop long-term protective immunity to the infecting serotype but not to other serotypes. During a second infection with a different serotype, the risk of severe disease is greater because cross-reactive immunity can exacerbate the disease. Efforts to develop DEN vaccines have been hampered by the dual role of immunity in protection and pathogenesis. We know very little about the antibody repertoire in people who have been infected with dengue. The main goal of this project is to use DENV3 as a model for defining the viral epitopes engaged by human antibody and to determine the functional outcome of these interactions. Our overall hypothesis is that a neutralizing antibody response is directed towards type-specific epitopes on domain III of E protein, whereas a non-neutralizing and potentially pathogenic antibody response is directed towards cross-reactive epitopes on domains I and II of E protein.
In aim 1 tudies will be done to produce human monoclonal antibodies from people who have recovered from DENV nfections.
In aim 2 a selected subset of human MAbs will be mapped to specific epitopes and functionally characterized for neutralizing or enhancing activity using cell culture and an animal model. The current dogma is that the main type-specific neutralization epitopes are conserved within each serotype. Our preliminary studies indicate that surface exposed regions on E protein of DENV3 are highly variable between trains.
In aim 3 we will determine if the main antibody epitopes are conserved among DENV3 strains. This project takes advantage of a panel of reagents including well characterized virus strains, human samples and a DENV3 infectious clone available at UNC. The project also utilizes antibody and protein cores available within SERCEB as well as a new rodent model of DENV developed by a SERCEB investigator. The study is expected to reveal mechanisms of antibody mediated neutralization or enhancement of DENV3. This information is directly applicable to the evaluation of the safety and efficacy of candidate dengue vaccines.

Public Health Relevance

Dengue is an emerging virus responsible for severe disease in tropical countries. The most practical solution to dengue is to develop a safe and effective vaccine. We propose to study how human antibodies neutralize dengue virus. The studies are directly relevant to developing and evaluating vaccines.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-DDS-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Dethoff, Elizabeth A; Boerneke, Mark A; Gokhale, Nandan S et al. (2018) Pervasive tertiary structure in the dengue virus RNA genome. Proc Natl Acad Sci U S A 115:11513-11518
Graham, Rachel L; Deming, Damon J; Deming, Meagan E et al. (2018) Evaluation of a recombination-resistant coronavirus as a broadly applicable, rapidly implementable vaccine platform. Commun Biol 1:179
Qi, Xiaoxuan; Wang, Wenjian; Dong, Haohao et al. (2018) Expression and X-Ray Structural Determination of the Nucleoprotein of Lassa Fever Virus. Methods Mol Biol 1604:179-188
Kocher, Jacob F; Lindesmith, Lisa C; Debbink, Kari et al. (2018) Bat Caliciviruses and Human Noroviruses Are Antigenically Similar and Have Overlapping Histo-Blood Group Antigen Binding Profiles. MBio 9:
Dhanwani, Rekha; Huang, Qinfeng; Lan, Shuiyun et al. (2018) Establishment of Bisegmented and Trisegmented Reverse Genetics Systems to Generate Recombinant Pichindé Viruses. Methods Mol Biol 1604:247-253
Shao, Junjie; Liu, Xiaoying; Liang, Yuying et al. (2018) Assays to Assess Arenaviral Glycoprotein Function. Methods Mol Biol 1604:169-178
Huang, Qinfeng; Shao, Junjie; Liang, Yuying et al. (2018) Assays to Demonstrate the Roles of Arenaviral Nucleoproteins (NPs) in Viral RNA Synthesis and in Suppressing Type I Interferon. Methods Mol Biol 1604:189-200
Gunn, Bronwyn M; Jones, Jennifer E; Shabman, Reed S et al. (2018) Ross River virus envelope glycans contribute to disease through activation of the host complement system. Virology 515:250-260
Shao, Junjie; Liang, Yuying; Ly, Hinh (2018) Roles of Arenavirus Z Protein in Mediating Virion Budding, Viral Transcription-Inhibition and Interferon-Beta Suppression. Methods Mol Biol 1604:217-227
Wirawan, Melissa; Fibriansah, Guntur; Marzinek, Jan K et al. (2018) Mechanism of Enhanced Immature Dengue Virus Attachment to Endosomal Membrane Induced by prM Antibody. Structure :

Showing the most recent 10 out of 400 publications